august 24 2025 glp-1 drugs have taken the world by storm, helping many people lose 11%–16% of their body weight. But a new Cochrane review reveals something surprising: the evidence supporting these blockbuster injections isn't GLP-1 Pipeline Update: August 2025

developed an inhaled nanosuspension (NS) formulation of NTB (NTB-NS) composed entirely of FDA-approved excipients, including polysorbate 80, a surfactant with an established clinical safety profile in the respiratory tract

It may also ease breast tenderness, cramping, headaches, bloating, and other issues that can show up just before you get your period

I still believe health cannot be judged by body size

Expand Your Laboratory Knowledge Explore Frontier Peptide Labs educational resources covering BPC-157 research, TB-500 research, research peptide blends, peptide combination research, peptide purity testing, HPLC analysis, LC-MS verification, laboratory handling, storage recommendations, analytical chemistry, peptide quality control, and scientific peptide research

Subcutaneous injection sites There are several common subcutaneous injection sites, all of which are places on the body with a layer of fatty tissue under the skin